Clinical Research and Outcomes Registry Workshop Creating an Informed Consent Form Daniel Ford, MD, MPH Joseph Carrese, MD.

Slides:



Advertisements
Similar presentations
Planning and preparing the national HES EHES Training seminar, Rome 11 February 2010 Päivikki Koponen.
Advertisements

What Should You Know and Be Doing About Genome Privacy? Ellen Wright Clayton, MD, JD Center for Biomedical Ethics and Society Vanderbilt University.
Topic 1 What is patient safety?. Learning objective Understand the discipline of patient safety and its role in minimizing the incidence and impact of.
Importance of a Registry Amy Belisle, MD Laura Brann, Program Manager, CIR Eric Anderson, Dir. Quality Data Management Chapter Quality Network (CQN) Asthma.
The Veterans Affairs Central Biorepository and MVP Highlights Mary T
Brave New World: Understanding and Managing Privacy Programs in an E-Health World e-Health Conference 2013: Accelerating Change May 28, 2013, a.m.
Influenza Vaccine Surveillance System Pilot Project Pandemic Influenza Vaccine: Doses Administered and Safety Training Conference Atlanta, GA—Aug. 22,
Protecting the Privacy of Family Members in Survey and Pedigree Research Jeffrey R. Botkin, MD, MPH University of Utah.
Improving Quality, Addressing Disparities, and Achieving Equity Language Barriers and Health Care Joseph R. Betancourt, M.D., M.P.H. Director, The Disparities.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Obtaining Informed Consent: 1. Elements Of Informed Consent 2. Essential Information For Prospective Participants 3. Obligation for investigators.
Use of Children as Research Subjects What information should be provided for an FP7 ethical review?
Data Collection – Beyond Baseline SPECIAL DIABETES PROGRAM FOR INDIANS Healthy Heart Project Initiative: New Program Training March 9, 2011.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Technical Assistance Meeting.
Core Elements: Case Management Recruitment Yvette Roubideaux, MD, MPH.
Informed Consent and HIPAA Tim Noe Coordinating Center.
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
CONSULTATION LETTER WRITING AND DICTATION AMBULATORY INTERNAL MEDICINE GROUP PRACTICE CLINIC Dr. Danny Panisko Updated by Katina Tzanetos Division of General.
International Forum - Quality & Safety in Healthcare |1 | An overview of the Guidance points Ethical issues in Patient Safety Research An overview.
IMIC, Inc a member of Akta Medika Group Research Department October, 2013 Las Vegas | USA MAGI West Patient Recruitment Excellence in everything we do!
D etection of E arly Lung C ancer A mong M ilitary P ersonnel Study 1 Version
SYNOPSIS OF THE PROTOCOL Title: Pregnancy Associated Breast Cancer (PABC); Prospective Data Registry in Saudi Arabia Sponsor: Oncology Department, King.
Francis Muma, BSc.N, MPH. Fellow, University of Nairobi Institute of Tropical and Infectious Diseases (UNITID). HIV Programme Management and Policy Track.
Paula Peyrani, MD Medical/Project Director, HIV Program at the 550 Clinic Assistant Director, Research Design and Development Clinical and Translational.
Treuman Katz Center for Pediatric Bioethics Conference Banking Biological Samples for Pediatric Research Jeffrey R. Botkin, M.D., M.P.H. Professor.
Consent2Share Linking Cohort Discovery to Consent David R Nelson MD Assistant Vice President for Research Professor of Medicine Director, Clinical and.
Conducting a Study Safely and Efficiently at Johns Hopkins Daniel E Ford, MD, MPH Vice Dean for Clinical Investigation July 20, 2010.
Implications for the Use of Tissue in Research P. Pearl O’Rourke, MD Partners HealthCare Boston, MA.
Adult-Onset Disease The Example of Colon Cancer Summer, 2012.
Anticipated FY2016 Appropriations Agency$ Million NIH200 Cancer70 Cohort130 FDA10 Office of the Natl Coord. for Health IT (ONC) 5 TOTAL215 Mission: To.
100k Genomes Project In December 2012 the Prime Minister announced a programme of Whole Genome Sequencing as part of the UK Government’s Life Sciences.
ACRIN 6685 Overview ACRIN 6685 A Multi-center Trial of FDG-PET/CT Staging of Head and Neck Cancer and its Impact on the N0 Neck Surgical Treatment in Head.
Neurodevelopmental Disorders Research Center Subject Registry Core A Brief Overview 6/28/2007 University of North Carolina Neurodevelopmental Disorders.
MESOTHELIOMA SPECIALTY CARE CENTER (SCC) HILLMAN CANCER CENTER.
Consent for Research Study A study for patients newly diagnosed with advanced glioblastoma (brain cancer): Learning whether a PET scan with F-fluoromisonidazole.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
HIPAA and Human Subjects Research IRB Member CE May 2014 Slideshow by Sean Horkheimer.
100k Genomes Project Programme of Whole Genome Sequencing, part of UK Life Sciences Strategy Aim to sequence 100,000 genomes from patients with cancer.
Personal Health Budgets Evaluation Evaluation of the Personal Health Budgets Pilots Wider Cohort Pilot Sites.
Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.
HUMAN TESTING: Ethical or unethical?. What is human testing? ■Human subjects research: any research or clinical investigation that involves human subjects.
Chronic Disease Tracking System  Problem  The current healthcare model focuses on one patient at a time in the office.  Chronic disease leads to higher.
“Translational research includes two areas of translation. One (T1) is the process of applying discoveries generated during research in the laboratory,
Controlled Data Access for Precision Medicine: An Acceptable Trade-off? Yann Joly, Ph.D.
Certificates of Confidentiality:
Do Short-Term Medical Trips Make a Difference in Treating NCDs? Mark Ryan, MD Goldie Chang, P3; Camille Hochheimer, PhD student; Marwah Khalid, MD; Dien.
HIPAA 2017 JHSPH IRB Clarifications and Changes
CLINICAL TRIALS.
A FRUIT AND VEGETABLE PRESCRIPTION PROGRAM
Week 5: Ethical, Legal & Social Issues in Applied Genomics
The Patient Experience With Systemic Lupus Erythematosus
Introduction to Direct-to-Consumer Genetic Testing
Design, Testing, and Use of a Pre-Visit Questionnaire to Improve CF Care Brooke Moore, M.D., MPH Pediatric Pulmonologist.
NR 305 Competitive Success-- snaptutorial.com
NR 305Competitive Success/tutorialrank.com
NR 305 Education for Service-- snaptutorial.com
NR 305 Education for Service-- tutorialrank.com. NR 305 Week 3 Family Genetic History For more course tutorials visit Family Genetic.
NR 305 Teaching Effectively-- snaptutorial.com
Find and Treat All Missing Persons with TB
How we use Your Health Records
The effect of high intensity interval training and surgical weight loss on distal symmetric polyneuropathy outcomes HUM Principal Investigator:
Informed Consent (SBER)
Cindy Murray NP Princess Margaret Cancer Centre
Figure 1 Essential features and goals of a precision medicine system
Health Information Systems: Functional Capacity
Figure A (online only) Flow diagram showing case recruitment, participation and follow up to the three year interview for the Prostate Cancer Care and.
Assignment 2 Learning Aim D: Individual Treatment Plan
SYNOPSIS OF THE PROTOCOL
MX Notice of Privacy Practices
Presentation transcript:

Clinical Research and Outcomes Registry Workshop Creating an Informed Consent Form Daniel Ford, MD, MPH Joseph Carrese, MD

What is the purpose of the study? Basic science discovery (ex. Biomarkers) Understand treatment and outcomes relationship Quality improvement at group level Quality improvement at individual level

Characteristics of Sample All patients Highly motivated patients Patients with very well characterized disease state

What are biggest risks to patients? Loss of privacy Impact on insurability Financial obligations (copays for services) Risks of assessments/procedures (ex, radiation risk) Clinicians acting on research data when value of information is not proven

Fundamental Questions How will participants be recruited? What data will be collected? Who can access the data? –Under what circumstances? –Group or individual level data? What will be allowed in terms of followup? How can a participant leave the study?

What data are collected? Standard of care assessments –Patient history, physical, lab and imaging tests, treatment received Research questionnaires Research physical assessments Research laboratory data Research biospecimens Research imaging data

Recruitment Clinician investigators recruit research participants during visits Other clinicians recruit research participants during visits Ask for HIPPA waiver to directly contact potential research participants

Access to Data Only research team Feedback all data to clinicians Feedback only “extreme and actionable” data to clinicians Copy of data to participants Copy of data in EMR/medical record Broad access to “group level data”

Followup Recontact for reassessments – improve precision through multiple measurements Ability to followup after leave health system How long will the study last? Social security number

Leaving the study Need to emphasize leaving study will not impact on their ability to get care What happens to biospecimens when patient asks to leave study?

Practical Questions Who obtains informed consent? Conflict of interest issues Do you want a consent form with several options? If so, who keeps track of options checked. Do you want separate consent forms? Incidental findings policy Genetic testing policy